Iontophoretic preparation for treatment of breast cancer and/or mastitis
The present invention is to provide means to treat breast cancer and/or mastitis by topically administering a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent and allowing them efficiently to arrive into the mammary gland. The present invention provides an iontophoretic preparation for treating breast cancer and/or mastitis which contains a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent as an active ingredient and has a donor to be applied on a nipple part for topical administration of the active ingredient from the nipple part to the mammary gland by application of electric potential.
1. An iontophoretic therapy for treating breast cancer and/or mastitis, wherein the therapy comprises applying a donor which contains an anticancer agent as an active ingredient on a nipple part and topically administering the active ingredient from the nipple part into a mammary gland by applying electric potential.
2. The therapy according to claim 1 , wherein the anticancer agent is cyclophosphamide or fluorouracil.
3. The therapy according to claim 1 , wherein the donor comprises an electrode and a pad containing the active ingredient.
4. The therapy according to claim 1 , wherein the therapy comprises applying a receptor on the breast part.
5. The therapy according to claim 3 , wherein the therapy comprises applying the donor on the nipple part and applying the receptor on the breast part and the donor has a size to cover the nipple and the receptor has a size to cover at least an affected part of the breast.
6. The therapy according to claim 5 , wherein the receptor is in a form of a disk or an oval disk which covers up the whole breast except the nipple part.
7. The therapy according to claim 4 , wherein the therapy comprises applying the donor on the nipple part and applying the receptor on the breast part and the donor has a size to cover the nipple and the receptor has a size to cover at least an affected part of the breast.
8. The therapy according to claim 2 , wherein the donor comprises an electrode and a pad containing the active ingredient.
9. The therapy according to claim 2 , wherein the therapy comprises applying a receptor on the breast part.
10. The therapy according to claim 3 , wherein the therapy comprises applying a receptor on the breast part.